Recurrent Breast Cancer Clinical Trials
2 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Metastatic Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerRecurrent Breast Cancer
Puma Biotechnology, Inc.150 enrolled53 locationsNCT06369285
Recruiting
Phase 1
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
Metastatic Breast CancerRecurrent Breast Cancer
Sun Yat-sen University20 enrolled1 locationNCT06900647
Recruiting
Not Applicable
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
Breast CancerBreast CarcinomaRecurrent Breast Cancer
Alpha Tau Medical LTD.10 enrolled1 locationNCT06202118
Recruiting
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer
Recurrent Breast Cancer
Hospital Clinic of Barcelona97 enrolled1 locationNCT06329089
Recruiting
Phase 1Phase 2
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Metastatic Breast CancerRecurrent Breast CancerAdvanced Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.154 enrolled2 locationsNCT06202261